News & Events

For Immediate Release

Bookmark & Share
Contact: Joan Boyce, 914-740-2100, jboyce@genengnews.com
GEN’s Next Cryptogram Challenge on qPCR Has Begun

New Rochelle, NY, October 18, 2010---Ready for GEN’s next Cryptogram Challenge? It’s based on qPCR, so prepare to put your lab skills to the test on this quarter’s online contest. Along with partner Scintellix, LLC and sponsor Bio-Rad Laboratories, Inc., we have launched the Cryptrogram Challenge: qPCR.

Crack the code and win $1,500 and a benchtop device from Bio-Rad. The first 150 people to register will receive a free T-shirt depicting the colorful Cryptogram image, so register now

All you have to do is decipher the cryptic message hidden in the image, which combines the quantitative output of a qPCR experiment with a set of swirling DNA bases as if they are in solution at the high temperature point of a PCR cycle. “Within this image lies an interesting cryptographic message that only the astute observer will discern,” says Peter C. Johnson, M.D., Cryptogram Creator and President and CEO of Scintellix.

The qPCR Challenge is the eighth in a series of online, cipher-based contests created by Dr. Johnson and hosted by GEN. “With every contest, we’ve ramped up the level of complexity to draw more life scientists and biotech professionals into pitting their wits against our Challenges,” remarks Joan Boyce, Director and Group Publisher of GEN. “The qPCR Challenge promises to intrigue the problem solver in you.”

Bio-Rad, which also sponsored two previous Cryptogram Challenges, will provide the qPCR winner with the opportunity to choose one benchtop instrument from the following: a Gene Pulser Xcell™ eukaryotic electroporation system, MyCycler™ personal thermal cycler, TC10™ automated cell counter, VersaFluor™ fluorometer, or SmartSpec™ Plus spectrophotometer. To get details on each product, click here.

“Bio-Rad is once again excited to sponsor the Cryptogram Challenge in search of the next ‘cellebrity,’” says Michelle Collins, Global Product Manager, Bio-Rad. “The qPCR challenge completes the ‘cellebrity’ series based on the Bio-Rad gene-expression workflow (electroporation, cell counting, and qPCR). We’re confident that people will find the latest challenge to be fun with an educational twist that researchers will appreciate.”

The first clue for the qPCR Challenge is: The image is a stylized readout of a quantitative PCR experiment. The bases, A, T, G, and C, are artistically displayed within the readout as if in solution.
 
New clues will be posted every Monday on the Cryptogram website to nudge you in the right direction. The contest will close once the cipher has been correctly decoded. The first person to reveal the message will be featured in GEN.
About the Partnership
GEN and Scintellix, LLC have formed a partnership to explore the hidden meaning found in biological imagery. The Cryptogram Challenge: qPCR is the eighth installment of the partnership. For more information visit the Cryptogram website.

About GEN
Genetic Engineering & Biotechnology News (GEN) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, like news and analysis as well as blogs, podcasts, webinars, polls, videos, and application notes. Additionally, GEN hosts a networking platform called GENconnect, which comprises Communities such as All Things PCR, Next-Generation Sequencing, Biomarkers, and more. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization. For more information visit the GEN website.

About Scintellix, LLC
Scintellix, LLC applies decision analysis methodologies to support the resolution of complex problems in personal and corporate development. The company is located in Raleigh, NC. For more information visit the Scintellix website.

About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The company employs over 6,800 people globally and had revenues of nearly $1.8 billion in 2009. For more information visit the Bio-Rad website.